GAMP 5 update: computerized system expectations for pharma manufacturers
European Pharmaceutical Review
NOVEMBER 15, 2022
This aligns well with newly-issued FDA draft guidance on Computer Software Assurance, which states: “Because the computer software assurance effort is risk-based, it follows a least-burdensome approach, where the burden of validation is no more than necessary to address the risk.” FDA, 2022. . About the authors.
Let's personalize your content